...
机译:作为新型乙型肝炎病毒衣壳胶囊抑制剂的酞嗪酮衍生物的发现
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med Lab Immunopharmacol Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;
机译:作为新型乙型肝炎病毒衣壳胶囊抑制剂的酞嗪酮衍生物的发现
机译:减轻CYP3A4诱导的新方法导致有效乙型肝炎病毒(HBV)衣壳抑制剂的发现,具有最佳备注谱
机译:发现乙型肝炎病毒衣壳组装抑制剂,导致杂芳基吡啶基酰亚胺基于临床候选者(GLS4)
机译:表位 - 远端效应伴随着两个不同抗体对乙型肝炎病毒衣壳的结合
机译:N5-CAIR细菌和丙型肝炎病毒NS3蛋白酶抑制剂的药物发现和抑制剂设计
机译:调节乙型肝炎病毒衣壳组装的苯甲酰胺衍生物的发现和机理研究
机译:减轻CYP3A4诱导的新方法导致有效乙型肝炎病毒(HBV)衣壳抑制剂的发现,具有最佳备注谱